Luis Miguel Valor Becerra-rekin lankidetzan egindako argitalpenak (8)

2021

  1. Potential diagnostic value of the differential expression of histone h3 variants between low-and high-grade gliomas

    Cancers, Vol. 13, Núm. 21

2020

  1. Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Transcriptional correlates of the pathological phenotype in a Huntington’s disease mouse model

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Early alteration of epigenetic-related transcription in Huntington's disease mouse models

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. The transcriptional profiling of human in vivo-generated plasma cells identifies selective imbalances in monoclonal gammopathies

    PLoS ONE, Vol. 12, Núm. 8

2002

  1. Transcription factors NF-Y and Sp1 are important determinants of the promoter activity of the bovine and human neuronal nicotinic receptor β4 subunit genes

    Journal of Biological Chemistry, Vol. 277, Núm. 11, pp. 8866-8876

2001

  1. Activity of the nicotinic acetylcholine receptor α5 and α7 subunit promoters in muscle cells

    DNA and Cell Biology, Vol. 20, Núm. 10, pp. 657-666

1999

  1. Multiple functional Sp1 domains in the minimal promoter region of the neuronal nicotinic receptor subunit gene

    Journal of Biological Chemistry, Vol. 274, Núm. 8, pp. 4693-4701